(Press-News.org) Admission to an intensive care unit (ICU) is associated with a small increased risk of future suicide or self-harm after discharge compared with non-ICU hospital admissions, finds a study published in The BMJ today.
The findings are particularly relevant during the covid-19 pandemic, as the number of ICU admissions around the world reach all-time highs.
The findings show that survivors of critical illness who later died by suicide or had self-harm events tended to be younger with a history of psychiatric illness, and had received invasive life support.
The researchers stress that the overall risk is still very low, but say knowledge of these factors "might allow for earlier intervention to potentially reduce this important public health problem."
Survival after critical illness is associated with important effects, including muscle weakness, reduced exercise capacity, fatigue, cognitive impairment, pain, and financial hardship. Growing evidence shows that ICU survivors have higher rates of psychiatric illness, but whether that translates into an increased risk of suicide and self-harm is unknown.
To explore this further, researchers in Canada and the US set out to analyse the association between survival from critical illness and suicide or self-harm after hospital discharge.
Their findings are based on health records for 423,000 adult ICU survivors (average age 62 years, 39% women) in Ontario, Canada from 2009 to 2017.
They matched health records for 423,000 adult ICU survivors (average age 62 years, 39% women) with 3 million non-ICU hospital survivors with similar risk factors for suicide in Ontario, Canada from 2009 to 2017.
Potentially influential factors including age, sex, mental health history, and previous hospitalisation for self-harm, were taken into account.
The researchers found that among ICU survivors, 750 patients (0.2%) died by suicide (41 per 100,000 person years over the study period) compared with 2,427 (0.1%) non-ICU hospital survivors (17 per 100,000 person years over the study period).
Self-harm was seen in 5,662 (1.3%) ICU survivors (328 per 100,000 person years over the study period) compared with 24,411 (0.8%) non-ICU hospital survivors (177 per 100,000 person years during the study period).
Overall, analysis showed that ICU survivors had a 22% higher risk of suicide compared with non-ICU hospital survivors and a 15% higher risk of self-harm. This increased risk was evident almost immediately after hospital discharge, and persisted for years afterwards.
Among the ICU survivors, the highest rates of suicide were seen in younger patients (ages 18-34), those with pre-existing diagnoses of depression, anxiety or PTSD, and those who received invasive procedures such as mechanical ventilation or mechanical blood filtration due to kidney failure in the ICU.
This is a large study involving a cohort of consecutive ICU survivors from an entire population, with minimal missing data. However, given the observational design, the researchers cannot rule out the possibility that other unmeasured factors may have affected their results, and say these associations require further study.
"Survivors of critical illness have increased risk of suicide and self-harm, and these outcomes were associated with pre-existing psychiatric illness and receipt of invasive life support," they write.
"Knowledge of these prognostic factors might allow for earlier intervention to potentially reduce this important public health problem," they conclude.
INFORMATION:
Externally peer reviewed? Yes
Evidence type: Observational
Subjects: People
Israel is the first country to report national data on the Pfizer-BioNTech vaccine, with observational analysis showing that two doses provide more than 95% protection against COVID-19 infection, hospitalisation, and death, including among the elderly, at a time when the B.1.1.7 variant was the dominant strain.
A single dose of the vaccine was associated with 58% protection against infection, 76% against hospitalisation, and 77% against death, emphasising the importance of fully vaccinating adults.
Challenges to controlling the pandemic remain, including uncertainty about ...
R21/Matrix-M becomes the second malaria vaccine candidate ever to start a phase III licensure trial
This builds on the recent finding of high level efficacy of this vaccine in a phase IIb trial in children in Burkina Faso, published today in The Lancet
The first phase III trial doses were administered by the team at the Malaria Research and Training Centre, Bamako, Mali, one of five trial sites across West and East Africa
The malaria vaccine was designed at the Jenner Institute, University of Oxford, who have partnered with the Serum Institute of India for commercial development
The annual death toll from ...
A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.
The discovery, made by researchers at the University of Illinois Chicago, could change current guidelines that recommend against genetic testing in people with atrial fibrillations, also known as AFib.
"We found that this new variant confers a significantly increased risk in African Americans, and this mutation has a 50% chance of being passed on to offspring," said Dr. Dawood Darbar, UIC professor of medicine and pharmacology at the College of Medicine. "Since it increases risk for heart failure, it would be wise to test people with atrial fibrillation to see if ...
According to a new study published in the journal Research in Social and Administrative Pharmacy, hospitals that participate in the 340B Drug Pricing Program provide more medication access services -- which are services that help remove barriers to accessing necessary medications -- than comparably sized non-340B hospitals.
The University of Illinois Chicago researchers who conducted the study, which included a survey of available services sent to a nationally representative sample of hospitals across the U.S., suggest that 340B participating hospitals may be better positioned to create and administer programs that support patients who are uninsured ...
Older people with kidney disease have a higher risk of dementia, and the risk increases with the rate and stage of kidney function decline. That is according to a large observational study by researchers at Karolinska Institutet in Sweden, published in the journal Neurology. The findings stress the significance of screening and monitoring for dementia in persons with kidney disease, the researchers say.
"Our study underscores the importance of low kidney function as a possible under-recognized risk factor for dementia," says co-author Juan Jesus Carrero, professor at the Department ...
With increased media attention and political campaigns focusing on the gender pay gap, the fact that women -- on average -- are paid less than men, has become an important public discussion. While much of the focus has been on the corporate sector, a new study that looked at executive compensation at nonprofit organizations found that women earn 8.9% less than men with the gap becoming greater when there is room for salary negotiations.
The study co-authored by Curtis Hall, PhD, an associate professor in Drexel University's LeBow College of Business; Andrew R. Finley, assistant professor at the Robert Day School of Economics and Finance at Claremont McKenna College; and LeBow College of Business doctoral student Amanda R. Marino, analyzed data from IRS ...
A multidisciplinary team of researchers from INRAP, CNRS, the universities of Ottawa, Rennes 2, Toulouse III Paul Sabatier and the Max Planck Institute has recognised the soldiers of the last battles of the siege of Rennes in 1491. These are the only witnesses of the forces involved in the conflict between the armies of Duchess Anne of Brittany and the King of France. This research and its methodology are currently the subject of two articles in the PLOS ONE review.
The excavation of the Jacobins convent in Rennes
From 2011 to 2013, a team from INRAP excavated the convent of the Jacobins, site of the future congress centre in Rennes Métropole, giving rise to numerous scientific ...
New Haven, Conn. -- A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being shared equitably among populations that participate in testing.
The study, published May 5 in JAMA Network Open, covers 34 novel drugs sponsored by large pharmaceutical companies that the U.S. Food and Drug Administration (FDA) approved between 2012 and 2014. Approvals were made on the basis of a total of 898 trials that were held in the United States and 70 other countries worldwide.
By analyzing the 563 trials for which location data was available, the researchers found that, five years after approval in the United States, only 15% of the drugs ...
By discovering a potential new cellular mechanism for migraines, researchers may have also found a new way to treat chronic migraine.
Amynah Pradhan, associate professor of psychiatry at the University of Illinois Chicago, is the senior author of the study, whose goal was to identify a new mechanism of chronic migraine, and propose a cellular pathway for migraine therapies. The study, "Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition, is published in eLife.
Pradhan, whose research focus is on the neurobiology of pain and headache, explained that the dynamic process of routing and rerouting connections among nerve ...
PHILADELPHIA-- It turns out that not all build-ups of tau protein are bad, and a team of researchers from the Perelman School of Medicine at the University of Pennsylvania developed a method to show that. Using mammalian cell models, the researchers combined extremely high-resolution microscopy with machine learning to show that tau actually forms small aggregates when a part of the body's normal physiology. Through this, they could distinguish between the aggregates occurring under healthy conditions from the ones associated with neurological diseases, potentially opening the door to screening for treatments that ...
